These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 17646283)
1. Prediction of metabolic clearance of bisphenol A (4,4 '-dihydroxy-2,2-diphenylpropane) using cryopreserved human hepatocytes. Kuester RK; Sipes IG Drug Metab Dispos; 2007 Oct; 35(10):1910-5. PubMed ID: 17646283 [TBL] [Abstract][Full Text] [Related]
2. Species difference of metabolic clearance of bisphenol A using cryopreserved hepatocytes from rats, monkeys and humans. Kurebayashi H; Okudaira K; Ohno Y Toxicol Lett; 2010 Oct; 198(2):210-5. PubMed ID: 20599483 [TBL] [Abstract][Full Text] [Related]
3. Human UDP-glucuronosyltransferase isoforms involved in bisphenol A glucuronidation. Hanioka N; Naito T; Narimatsu S Chemosphere; 2008 Dec; 74(1):33-6. PubMed ID: 18990428 [TBL] [Abstract][Full Text] [Related]
4. Comparison of fresh and cryopreserved rat hepatocyte suspensions for the prediction of in vitro intrinsic clearance. Griffin SJ; Houston JB Drug Metab Dispos; 2004 May; 32(5):552-8. PubMed ID: 15100178 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of cryopreserved human hepatocytes as an alternative in vitro system to microsomes for the prediction of metabolic clearance. Brown HS; Griffin M; Houston JB Drug Metab Dispos; 2007 Feb; 35(2):293-301. PubMed ID: 17132764 [TBL] [Abstract][Full Text] [Related]
6. Differences between human and rat intestinal and hepatic bisphenol A glucuronidation and the influence of alamethicin on in vitro kinetic measurements. Mazur CS; Kenneke JF; Hess-Wilson JK; Lipscomb JC Drug Metab Dispos; 2010 Dec; 38(12):2232-8. PubMed ID: 20736320 [TBL] [Abstract][Full Text] [Related]
7. Gender differences in the metabolism and pharmacokinetics of the experimental anticancer agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA). Zhou S; Kestell P; Tingle MD; Paxton JW Cancer Chemother Pharmacol; 2002 Feb; 49(2):126-32. PubMed ID: 11862426 [TBL] [Abstract][Full Text] [Related]
8. Assessment of cryopreserved human hepatocytes as a model system to investigate sulfation and glucuronidation and to evaluate inhibitors of drug conjugation. Riches Z; Bloomer J; Patel A; Nolan A; Coughtrie M Xenobiotica; 2009 May; 39(5):374-81. PubMed ID: 19280384 [TBL] [Abstract][Full Text] [Related]
9. Comparison of intrinsic metabolic clearance in fresh and cryopreserved human hepatocytes. Floby E; Johansson J; Hoogstraate J; Hewitt NJ; Hill J; Sohlenius-Sternbeck AK Xenobiotica; 2009 Sep; 39(9):656-62. PubMed ID: 19622023 [TBL] [Abstract][Full Text] [Related]
10. Altered AZT (3'-azido-3'-deoxythymidine) glucuronidation kinetics in liver microsomes as an explanation for underprediction of in vivo clearance: comparison to hepatocytes and effect of incubation environment. Engtrakul JJ; Foti RS; Strelevitz TJ; Fisher MB Drug Metab Dispos; 2005 Nov; 33(11):1621-7. PubMed ID: 16049128 [TBL] [Abstract][Full Text] [Related]
11. In vitro analysis of human drug glucuronidation and prediction of in vivo metabolic clearance. Soars MG; Burchell B; Riley RJ J Pharmacol Exp Ther; 2002 Apr; 301(1):382-90. PubMed ID: 11907196 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the modulatory effects of human and rat liver microsomal metabolism on the estrogenicity of bisphenol A: implications for extrapolation to humans. Elsby R; Maggs JL; Ashby J; Park BK J Pharmacol Exp Ther; 2001 Apr; 297(1):103-13. PubMed ID: 11259533 [TBL] [Abstract][Full Text] [Related]
13. Prediction of human hepatic clearance from in vivo animal experiments and in vitro metabolic studies with liver microsomes from animals and humans. Naritomi Y; Terashita S; Kimura S; Suzuki A; Kagayama A; Sugiyama Y Drug Metab Dispos; 2001 Oct; 29(10):1316-24. PubMed ID: 11560875 [TBL] [Abstract][Full Text] [Related]
14. Comparison of cryopreserved HepaRG cells with cryopreserved human hepatocytes for prediction of clearance for 26 drugs. Zanelli U; Caradonna NP; Hallifax D; Turlizzi E; Houston JB Drug Metab Dispos; 2012 Jan; 40(1):104-10. PubMed ID: 21998403 [TBL] [Abstract][Full Text] [Related]
15. Comparison of intrinsic clearance in liver microsomes and hepatocytes from rats and humans: evaluation of free fraction and uptake in hepatocytes. Lu C; Li P; Gallegos R; Uttamsingh V; Xia CQ; Miwa GT; Balani SK; Gan LS Drug Metab Dispos; 2006 Sep; 34(9):1600-5. PubMed ID: 16790553 [TBL] [Abstract][Full Text] [Related]
16. A unified model for predicting human hepatic, metabolic clearance from in vitro intrinsic clearance data in hepatocytes and microsomes. Riley RJ; McGinnity DF; Austin RP Drug Metab Dispos; 2005 Sep; 33(9):1304-11. PubMed ID: 15932954 [TBL] [Abstract][Full Text] [Related]
17. In vitro-in vivo correlation for drugs and other compounds eliminated by glucuronidation in humans: pitfalls and promises. Miners JO; Knights KM; Houston JB; Mackenzie PI Biochem Pharmacol; 2006 May; 71(11):1531-9. PubMed ID: 16455060 [TBL] [Abstract][Full Text] [Related]
18. Use of cryopreserved human hepatocytes in sandwich culture to measure hepatobiliary transport. Bi YA; Kazolias D; Duignan DB Drug Metab Dispos; 2006 Sep; 34(9):1658-65. PubMed ID: 16782767 [TBL] [Abstract][Full Text] [Related]
19. Estimating constants for metabolism of atrazine in freshly isolated rat hepatocytes by kinetic modeling. McMullin TS; Andersen ME; Tessari JD; Cranmer B; Hanneman WH Toxicol In Vitro; 2007 Apr; 21(3):492-501. PubMed ID: 17188835 [TBL] [Abstract][Full Text] [Related]
20. Effect of zonal transport and metabolism on hepatic removal: enalapril hydrolysis in zonal, isolated rat hepatocytes in vitro and correlation with perfusion data. Abu-Zahra TN; Pang KS Drug Metab Dispos; 2000 Jul; 28(7):807-13. PubMed ID: 10859155 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]